These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 32279544)

  • 1. Analysis of
    Torres Espíndola LM; Rojo-Serrato D; Álvaro-Heredia A; Castillejos López MJ; de Uña-Flores A; Pérez-García M; Zapata-Tarres M; Cárdenas-Cardos R; Granados J; Chávez-Pacheco JL; Salinas-Lara C; de Arellano IT; Aquino-Gálvez A
    Biomarkers; 2020 Jun; 25(4):331-340. PubMed ID: 32279544
    [No Abstract]   [Full Text] [Related]  

  • 2. The rs776746 variant of CYP3A5 is associated with intravenous midazolam plasma levels and higher clearance in critically ill Mexican paediatric patients.
    Flores-Pérez C; Castillejos-López MJ; Chávez-Pacheco JL; Dávila-Borja VM; Flores-Pérez J; Zárate-Castañón P; Acosta-Bastidas M; Cruz-Escobar J; Torres-Espíndola LM
    J Clin Pharm Ther; 2021 Jun; 46(3):633-639. PubMed ID: 33638195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of alleles, genotypes and haplotypes of the CYP2B6 (rs3745274; rs2279343) and CYP3A4 (rs2740574) genes in the Malian population: Implication for pharmacogenetics.
    Kassogue Y; Diakite B; Kassogue O; Konate I; Tamboura K; Diarra Z; Maiga M; Dehbi H; Nadifi S; Traore CB; Kamate B; Dao S; Doumbia S; Dolo G
    Medicine (Baltimore); 2021 Jul; 100(29):e26614. PubMed ID: 34398016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
    Duflot T; Marie-Cardine A; Verstuyft C; Filhon B; Pereira T; Massy-Guillemant N; Joannidès R; Bellien J; Lamoureux F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):337-342. PubMed ID: 29319893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxylation and N-dechloroethylation of Ifosfamide and deuterated Ifosfamide by the human cytochrome p450s and their commonly occurring polymorphisms.
    Calinski DM; Zhang H; Ludeman S; Dolan ME; Hollenberg PF
    Drug Metab Dispos; 2015 Jul; 43(7):1084-90. PubMed ID: 25934575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Effect of CYP2B6 Genotype and Other Candidate Genes on a Steady-State Serum Concentration of Methadone in Opioid Maintenance Treatment.
    Kringen MK; Chalabianloo F; Bernard JP; Bramness JG; Molden E; Høiseth G
    Ther Drug Monit; 2017 Oct; 39(5):550-555. PubMed ID: 28723731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide.
    Ekhart C; Doodeman VD; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Jun; 18(6):515-23. PubMed ID: 18496131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of
    Espindola LMT; López MJC; Flores AU; Espinosa LR; Granados J; Pacheco JLC; García MP; Cervantes MTR; Méndez VCB; Doño SH; Ruíz Gómez D
    Arch Med Sci; 2021; 17(6):1766-1771. PubMed ID: 34900058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
    López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
    Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation.
    McCune JS; Risler LJ; Phillips BR; Thummel KE; Blough D; Shen DD
    Drug Metab Dispos; 2005 Jul; 33(7):1074-81. PubMed ID: 15821045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the CYP2B6 gene with anti-tuberculosis drug-induced hepatotoxicity in a Brazilian Amazon population.
    Fernandes DC; Santos NP; Moraes MR; Braga AC; Silva CA; Ribeiro-dos-Santos A; Santos S
    Int J Infect Dis; 2015 Apr; 33():28-31. PubMed ID: 25271170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CYP2D6, CYP3A5, and CYP3A4 gene polymorphism in Russian, Tatar, and Bashkir populations].
    Mustafina OE; Tuktarova IA; Karimov DD; Somova Rs; Nasibullin TR
    Genetika; 2015 Jan; 51(1):109-19. PubMed ID: 25857198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anthocyanidins and anthocyanins on the expression and catalytic activities of CYP2A6, CYP2B6, CYP2C9, and CYP3A4 in primary human hepatocytes and human liver microsomes.
    Srovnalova A; Svecarova M; Zapletalova MK; Anzenbacher P; Bachleda P; Anzenbacherova E; Dvorak Z
    J Agric Food Chem; 2014 Jan; 62(3):789-97. PubMed ID: 24387788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: a crucial role for the CYP2B6*6 allele.
    Hwang IC; Park JY; Ahn HY; Kim KK; Suh HS; Ko KD; Kim KA
    Clin Chim Acta; 2014 Jan; 428():77-81. PubMed ID: 24262967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study.
    Ju S; Gao Y; Cao X; Zhang XF; Yan CC; Liu FT
    Genet Test Mol Biomarkers; 2017 Sep; 21(9):539-546. PubMed ID: 28872889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.
    Mutagonda RF; Kamuhabwa AAR; Minzi OMS; Massawe SN; Asghar M; Homann MV; Färnert A; Aklillu E
    Malar J; 2017 Jul; 16(1):267. PubMed ID: 28673292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study.
    Garcia-Donas J; Esteban E; Leandro-García LJ; Castellano DE; González del Alba A; Climent MA; Arranz JA; Gallardo E; Puente J; Bellmunt J; Mellado B; Martínez E; Moreno F; Font A; Robledo M; Rodríguez-Antona C
    Lancet Oncol; 2011 Nov; 12(12):1143-50. PubMed ID: 22015057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of the CYP3A4, CYP3A5, CYP3A7 and CYP1A2 among the Jordanian population.
    Salameh G; Al Hadidi K; El Khateeb M
    Environ Toxicol Pharmacol; 2012 Jul; 34(1):23-33. PubMed ID: 22426036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide.
    Labib RM; A Abdelrahim ME; Elnadi E; Hesham RM; Yassin D
    PLoS One; 2016; 11(7):e0158890. PubMed ID: 27388155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.